Skip to main content

Decompression with or without Duraplasty for Chiari I and Syringomyelia.

Journal articles  - Journal Article, Multicenter Study
Limbrick, DD; Shannon, CN; Bayman, EO; Meehan, T; Kallem, M; Ackerman, LL; Adelson, PD; Ahmed, R; Albert, G; Aldana, PR; Alden, TD; Baird, LC ...
Published in: N Engl J Med
May 28, 2026

BACKGROUND: In children with Chiari type I malformation and syringomyelia, neurosurgical posterior fossa decompression (PFD) provides clinical improvement, but whether duraplasty (incising the dura and placing a dural graft) improves outcomes is unclear. METHODS: We conducted a multicenter, cluster-randomized, controlled trial of PFD with duraplasty (PFD-D) as compared with PFD alone. Persons 21 years of age or younger with cerebellar tonsillar ectopia of at least 5 mm and a maximum syrinx diameter of 3.0 to 9.9 mm were enrolled at 38 centers. Centers were cluster-randomized: all the participants within each center underwent the same intervention. The primary outcome was surgical complications within 6 months. Secondary outcomes were clinical improvement, syrinx reduction, and repeat decompression at 10 to 24 months and the change in overall health-related quality of life at 6 to 24 months. RESULTS: A total of 162 participants were included in the trial, of whom 78 were assigned to undergo PFD-D and 84 to undergo PFD alone. The percentage of participants with complications within 6 months was 14% with PFD-D and 6% with PFD (adjusted odds ratio, 2.59; 95% confidence interval [CI], 0.86 to 7.84; P = 0.11). At 24 months, the percentage of participants with clinical improvement was 58% with PFD-D and 46% with PFD; the mean (±SD) syrinx reduction was 3.08±2.33 mm and 1.22±1.79 mm, respectively; and the percentage of participants with repeat decompression was 3% and 14%. Changes in health-related quality of life were similar in the two groups. CONCLUSIONS: The percentage of participants with surgical complications did not differ significantly between those who underwent PFD-D and and those who underwent PFD alone. Larger trials are needed to determine the relative benefits and risks of these two procedures. (Funded by the Patient-Centered Outcomes Research Institute and others; ClinicalTrials.gov number, NCT02669836.).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

May 28, 2026

Volume

394

Issue

20

Start / End Page

2015 / 2025

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Syringomyelia
  • Spinal Cord
  • Reoperation
  • Quality of Life
  • Postoperative Complications
  • Male
  • Magnetic Resonance Imaging
  • Humans
  • General & Internal Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Limbrick, D. D., Shannon, C. N., Bayman, E. O., Meehan, T., Kallem, M., Ackerman, L. L., … Park-Reeves Syringomyelia Research Consortium Investigators. (2026). Decompression with or without Duraplasty for Chiari I and Syringomyelia. N Engl J Med, 394(20), 2015–2025. https://doi.org/10.1056/NEJMoa2402821
Limbrick, David D., Chevis N. Shannon, Emine O. Bayman, Thanda Meehan, Marisa Kallem, Laurie L. Ackerman, P David Adelson, et al. “Decompression with or without Duraplasty for Chiari I and Syringomyelia.N Engl J Med 394, no. 20 (May 28, 2026): 2015–25. https://doi.org/10.1056/NEJMoa2402821.
Limbrick DD, Shannon CN, Bayman EO, Meehan T, Kallem M, Ackerman LL, et al. Decompression with or without Duraplasty for Chiari I and Syringomyelia. N Engl J Med. 2026 May 28;394(20):2015–25.
Limbrick, David D., et al. “Decompression with or without Duraplasty for Chiari I and Syringomyelia.N Engl J Med, vol. 394, no. 20, May 2026, pp. 2015–25. Pubmed, doi:10.1056/NEJMoa2402821.
Limbrick DD, Shannon CN, Bayman EO, Meehan T, Kallem M, Ackerman LL, Adelson PD, Ahmed R, Albert G, Aldana PR, Alden TD, Anderson RCE, Baird LC, Bauer D, Bethel-Anderson T, Bierbrauer K, Brockmeyer DL, Chern JJ, Couture DE, Daniels DJ, Dauser RC, Dlouhy BJ, Durham SR, Ellenbogen RG, Eskandari R, Gannon SR, Grant GA, Graupman PC, Greenberg JK, Greene S, Greenfield JP, Gross NL, Guillaume DJ, Hankinson TC, Heuer G, Iantosca M, Iskandar BJ, Jackson EM, Jallo GI, Johnston JM, Keating RF, Kelly MP, Kennedy E, Krieger MD, Kulkarni AV, Labuda R, Leonard JR, Maher CO, Mangano FT, McComb JG, McEvoy SD, McKinstry RC, Menezes AH, Niazi TN, Oakes J, Olavarria G, O’Neill BR, Poppe D, Ragheb J, Reeves S, Reynolds L, Selden NR, Shah MN, Shimony JS, Smyth MD, Spears S, Stone SSD, Strahle JM, Tamber M, Tramelli G, Tuite GF, Tyler-Kabara EC, Vance H, Wait SD, Wellons JC, Whitehead WE, Yahanda AT, Yan Y, Dacey RG, Park TS, Torner JC, Park-Reeves Syringomyelia Research Consortium Investigators. Decompression with or without Duraplasty for Chiari I and Syringomyelia. N Engl J Med. 2026 May 28;394(20):2015–2025.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

May 28, 2026

Volume

394

Issue

20

Start / End Page

2015 / 2025

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Syringomyelia
  • Spinal Cord
  • Reoperation
  • Quality of Life
  • Postoperative Complications
  • Male
  • Magnetic Resonance Imaging
  • Humans
  • General & Internal Medicine